David J. Pinato

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Dominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol et al. · Nature · 2021 · 1.2K citations · Full text

Life Sciences, Immunology, Oncology +17

Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer

David J. Pinato, Sarah Howlett, Diego Ottaviani et al. · JAMA Oncology · 2019 · 593 citations · Full text

Medicine, Oncology, Pharmacology +15

A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)

David J. Pinato, Bernard V. North, Rohini Sharma · British Journal of Cancer · 2012 · 425 citations · Full text

Agriculture, Nutrition, Oncology +17

The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma

David J. Pinato, Rohini Sharma, Elias Allara et al. · Journal of Hepatology · 2016 · 417 citations · Full text

Medicine, Oncology, Pathology +14

Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score

Bernhard Scheiner, Katharina Pomej, Martha M. Kirstein et al. · Journal of Hepatology · 2021 · 300 citations · Full text

Pharmacy, Immunology, Oncology +17